25 GHP Healthcare and Pharmaceutical Awards 2026 eraphina Therapeutics is a health and wellness company leading the charge on US Navy-funded longevity-enhancing technologies. Co-founded by Dr Stephanie Venn- Watson, who is also its co-CEO, the brand is responsible for fatty15, the patented, science-backed, award-winning C15:0 supplement that supports healthy ageing and promotes long-term wellness. For more on this supplement and the story behind it, we caught up with Dr Venn-Watson herself. During her time caring for older Navy dolphins, which are part of the United States Navy’s Marine Mammal Program, Dr Stephanie Venn-Watson discovered C15:0 as the first essential fatty acid to emerge since omega-3. Her discovery, driven by the findings that the healthiest ageing dolphins had higher levels of C15:0, led to the creation of the C15:0 supplement fatty15, which targets multiple longevity pathways and also slows cellular ageing to support improved health and wellness at all ages. The resulting Seraphina Therapeutics was founded to democratise longevity, with recent data supporting that C15:0 deficiency may be accelerating ageing in as many as one in three people. This is because our primary dietary source of C15:0 is whole dairy fat, and thanks to its systematic decline in modern diets, levels have decreased population wide. Low levels of C15:0 in the cell membrane can trigger a form of cell death called ‘ferroptosis’, which accelerates the onset of age-related diseases such as type 2 diabetes and dementia. “There are over 100 peer-reviewed papers from independent teams throughout the world supporting the long-term health benefits of C15:0.” Complementing its belief that everyone deserves to live a longer and healthier life are the values of scientific integrity and accessibility, both of which guide Seraphina Therapeutics at every Best Essential Fatty Acid Supplement Brand 2026 – USA & GHP Customer Satisfaction Excellence Award 2026 turn. As Dr Venn-Watson explained: “By focusing on restoring and optimising C15:0 levels through improved diets and sustainable practices, we are moving the industry away from quick fixes and toward meaningful, evidence-based cellular health.” From the discovery of C15:0 as an emerging foundational nutrient to today, where her book on the subject, ‘The Longevity Nutrient’, published by Simon & Schuster, highlights the impact of the nutrient on tens of thousands of people in clinical trials, preclinical studies, and large prospective cohort meta-analyses, across a decade or more, the defining theme of Dr Venn-Watson’s work has been turning her breakthrough into a global mission to help restore individuals of every age to healthy levels of the C15:0 fatty acid. Her success is reflected in more than 7,000 five-star reviews. Of course, there have been challenges to overcome, as longevity supplements that serve as ‘geroprotectors’ (molecules that slow the onset of the diseases that most severely impact our health) are difficult to test using standard clinical trials. This is why the team here are working on state-of-the-art methods using realworld data to demonstrate the success of C15:0. This aligns them with others in this space, including the FDA, who also recognise the limitations of clinical trials and the value of real-world data when it comes to health. Similarly, as Dr Venn-Watson told us: “The supplement industry often faces justified scepticism due to bad actors, the lack of quality ingredients, and a lack of transparency. Our biggest challenge has been educating the public about a nutrient – C15:0 – that most people have never heard of, despite its emerging essential nature.” Seraphina Therapeutics has done so with demonstrated transparency, quality, and education. “By anchoring everything we do in peer-reviewed science, available at DiscoverC15.com, we rise above the supplement noise and build long-term trust with our community.” As for what is next for the brand, Dr Venn-Watson and the team are excited to be expanding their family of fatty15 supplements to help other families age healthily Alongside the fatty15 C15:0 tiny & easy-to-swallow capsules, the most popular product in the line, recent introductions include fatty15 apple-mint gummies for adults, fatty15 berry-blast gummies for children, and fatty15 advanced formula, and extra-strength fatty15 capsules (the latter exclusively provided by physicians). Finally, commenting on the future of the C15:0 fatty acid, Dr VennWatson remarked: “With an average of one new peer-reviewed publication on C15:0’s health benefits being published per week from around the world, we are increasingly understanding the importance of C15:0 to support everyone’s longevity.” For its work in taking this longevity nutrient and making it accessible through a patented, science-backed, and award-winning supplement, we are delighted to recognise Seraphina Therapeutics with two awards in this programme. Contact: Dr Stephanie Venn-Watson Company: Seraphina Therapeutics (fatty15) Web Address: https://fatty15.com/ S Jul23706 Seraphina Therapeutics (fatty15)
RkJQdWJsaXNoZXIy MTUyMDQwMA==